Patent ID: 9403900
Filing Date: 2016-08-02
CPC Classification: A61K,A61P,C07K,C12N,G01N

Claim Text:
1. An anti-Respiratory Syncytial Virus (RSV) antigen-binding fragment of an antibody, wherein: the antigen-binding fragment comprises: a variable heavy (VH) chain containing a complementary region 1 (CDR1) comprising SEQ ID NO: 464 or 483; a complementary region 2 (CDR2) comprising SEQ ID NO: 465; and a complementary region 3 (CDR3) comprising SEQ ID NO: 466; and a variable light (VL) chain containing a CDR1 comprising SEQ ID NO: 467; a CDR2 comprising SEQ ID NO: 468; and a CDR3 comprising SEQ ID NO: 469; and wherein the antigen-binding fragment immunospecifically binds to Respiratory Syncytial Virus (RSV) fusion (F) protein and/or neutralizes RSV, and wherein the fragment is non-human, humanized, chimeric, and/or camelised.